Everolimus (Certican), Whole Blood

Specimen requirement

Adult patient:

 

EDTA tube

 

Minimum blood volume: 3 mL

Paediatric patient:

Paediatric EDTA tube

Number of vials: 1

Minimum blood volume: 1.3 mL

Authorisation code required

No

24 Hr available service

No

Precaution Trough level monitoring (pre-dose)

Method

Liquid chromatography-tandem mass spectrometry

Reference interval

3 - 8 µg/L

 

(Source: Norvatis Certican Summary of Product Characteristics)

Clinical indication

Therapeutic drug monitoring in patients receiving everolimus therapy to avoid rejection of organ transplants and to detect toxic levels.

Result interpretation

An elevated result provides an early indication of the possibility of toxicity.

Measurement of uncertainty

See table.

Frequency of measurement

Weekly